Nachrichten zur Illumina Inc. Aktie

Illumin gets TSK nod to proceed with NCIB

…

Massive Kursverluste für die Illumina-Aktie (105,1119 €)

Die Aktie von Illumina zählt heute zu den großen Verlierern an der Börse. Der Titel verliert deutlich an Wert. Zu…

2028 Global Nanopore Sequencing Market Forecast with Key Players: Oxford Nanopore Technologies, Illumina, Roche, 10X Genomics, and More

Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Nanopore Sequencing Market 2018-2028" report has been added to…

Global Hereditary Testing Market Size To Worth USD 13.14 Billion By 2032 | CAGR of 7.8%

The Global Hereditary Testing Market Size was valued at USD 6.20 Billion in 2022 and the Worldwide Hereditary Testing Market…

Illumina stock hits new 52-week low amid Grail divesture woes

…

illumin Announces Date for Third Quarter 2023 Financial Results Video Conference Call

TORONTO and NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- illumin (TSX: ILLM, OTC: ILLMF) (“illumin” or “Company”),…

Das Wertpapier von Illumina läuft schlechter: Große Kursverluste! (120,3599 €)

Die Aktie von Illumina zählt heute zu den großen Verlierern an der Börse. Der Titel verbilligt sich am Mittwoch deutlich.…

Activist Icahn sues Illumina board over Grail acquisition

Activist-investor Carl Icahn said his firm had sued current and former board directors at Illumina concerning the acquisition of gene-sequencing…

Activist Icahn sues Illumina board over Grail acquisition

Activist Icahn sues Illumina board over Grail acquisition - FT…

Carl Icahn reportedly sues former Illumina CEO, board members

…

Illumina to divest Grail within a year if it does not win challenge in EU court By Reuters

Illumina to divest Grail within a year if it does not win challenge in EU court…

: Illumina responds to EC Grail divestiture order

Illumina Inc. ILMN responded Friday to an order it received Thursday from the European Commission directing the company to…

Illumina-Aktie kann sich nicht behaupten: Kurs fällt um 3,76 Prozent (126,0087 €)

Die Aktie von Illumina zählt am Donnerstag zu den großen Verlierern an der Börse. Das Wertpapier verliert deutlich an Wert.…

EU antitrust regulators order Illumina to sell Grail By Investing.com

EU antitrust regulators order Illumina to sell Grail…

Illumina ordered to divest GRAIL unit in EU

…

Illumina ordered by EU antitrust regulators to sell Grail

U.S. genetic testing company Illumina has been ordered by EU antitrust regulators to sell cancer test maker Grail after it…

Illumina ordered by EU antitrust regulators to sell Grail By Reuters

Illumina ordered by EU antitrust regulators to sell Grail…

Illumina to quickly divest Grail if it loses EU or US appeal: report

…

Illumina to divest Grail if it loses final court appeals in US or EU By Reuters

Illumina to divest Grail if it loses final court appeals in US or EU…

Guten Morgen mit Uniper, Roche, AboutYou ...

*VILLEROY/EZB: DIE ZINSSÄTZE SIND JETZT AUF DEM RICHTIGEN NIVEAUROG SW - Roche erzielt mit Augenmittel Vabysmo weiteren Behandlungserfolg ILLUMINA -…

EU regulators to order Illumina to sell Grail - Financial Times By Investing.com

EU regulators to order Illumina to sell Grail - Financial Times…

Illumina falls amid reports of an EU order to sell Grail

…

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

Illumina: Kursziel gekürzt

London (www.aktiencheck.de) - Rating-Update: Die HSBC stuft die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol: ILU, NASDAQ-Symbol: ILMN) unverändert…

Global Epigenomics Market Research Report 2023-2031 Featuring Epigenomics AG, Illumina, Merck, Zymo Research, & Agilent Technologies

Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Epigenomics Market Report and Forecast 2023-2031" report has been…

Single-Cell Omics Market revenue to hit USD 30 Billion by 2035, says Research Nester

Prominent single-cell omics market players include 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina,…

Bernstein bullish on Thermo, Revvity, Guardant, PacBio; bearish on Illumina

…

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

Illumina-Aktie gewinnt 4,12 Prozent (130,2332 €)

Grund zur Freude haben Aktionäre von Illumina : Der Kurs der Aktie legt kräftig zu. Eine Steigerung um 4,12 Prozent…

Down 15% in 2023, Should You Buy the Dip With Illumina Stock?

Illuminas future is looking a bit dim at the moment....…

Illumina: Kurszielsenkung

Minneapolis (www.aktiencheck.de) - Rating-Update: Piper Sandler bestätigt das Rating "overweight" für die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol:…

Illumina under SEC investigation over GRAIL acquisition

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

SEC investigating Illumina over acquisition of cancer test developer Grail

Illuminas acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European…

UPDATE 1-US securities regulator probes Illumina over Grail deal

...(Adds shares in paragraph 3) Aug 11 (Reuters) - The U.S. Securities......…

US securities regulator probes Illumina over Grail deal

...(Reuters) - The U.S. Securities and Exchange Commission (SEC) has......…

Illumina (ILMN) Q2 Earnings Beat Estimates, Margins Contract

Illumina (ILMN) shipped 109 NovaSeq X instruments in the second quarter, boosting its supply capacity to more than 390 instruments…

Illumina Slashes Guidance Amid Cautious Consumer. What Wall Street Thinks.

Citi analyst Patrick Donnelly cut his price target on Illumina to $150 from $180....…

Illumina (ILMN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter…

UPDATE 1-Illumina cuts annual profit forecast as biotech funding woes linger

... in paragraph 6, 7 and 10) Aug 9 (Reuters) - Illumina Inc cut annual profit......…

Illumina 2Q Loss Narrows on Higher Sales of NovaSeq X Instruments

Illumina 2Q Loss Narrows on Higher Sales of NovaSeq X Instruments...…

Illumina stock falls, as ‘cautious consumer backdrop’ tempers outlook

Shares of Illumina Inc. slid 6.6% after hours on Wednesday after the DNA-sequencing company tempered its full-year sales outlook, amid…

Illumina Medical Chief Phil Febbo, Chief Technology Officer Aravanis Exit

Illumina Medical Chief Phil Febbo, Chief Technology Officer Aravanis Exit...…

Illumina Reduces Guidance On Cautious Consumers

Illumina Reduces Guidance On Cautious Consumers...…

Illumina cuts full year top and bottom line guidance, shares fall nearly 6% after hours

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Inc. Q2 Earnings Summary

SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: -$234 million in Q2 vs. -$535 million…

Illumina cuts annual profit forecast

...Aug 9 (Reuters) - Illumina Inc lowered annual profit forecast......…

Form 8-K ILLUMINA, INC. For: Aug 07

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Non-GAAP EPS of $0.32 beats by $0.30, revenue of $1.18B beats by $20M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ILLUMINA, INC. For: Aug 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina: How Genetic Technologies Can Empower More People With Information

Originally published on Illumina News CenterNORTHAMPTON, MA / ACCESSWIRE / August 9, 2023 / After earning a graduate degree in…